Prosecution Insights
Last updated: April 19, 2026
Application No. 18/564,842

CACAO FRUIT GROUND PRODUCT AND METHOD FOR PRODUCING THE SAME

Non-Final OA §102§112
Filed
Nov 28, 2023
Examiner
BEKKER, KELLY JO
Art Unit
1792
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Meiji Co. Ltd.
OA Round
1 (Non-Final)
16%
Grant Probability
At Risk
1-2
OA Rounds
4y 4m
To Grant
50%
With Interview

Examiner Intelligence

Grants only 16% of cases
16%
Career Allow Rate
64 granted / 409 resolved
-49.4% vs TC avg
Strong +34% interview lift
Without
With
+34.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 4m
Avg Prosecution
73 currently pending
Career history
482
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
42.1%
+2.1% vs TC avg
§102
15.0%
-25.0% vs TC avg
§112
32.9%
-7.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 409 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group II, claims 5-7 in the reply filed on November 7, 2025 is acknowledged. Claims 1-4 and 8-9 have been withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Drawings The drawings are objected to because: in the Brief Description of Drawings no description for Figures 9 and 10 was found. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Specification The following guidelines illustrate the preferred layout for the specification of a utility application. These guidelines are suggested for the applicant’s use. Arrangement of the Specification As provided in 37 CFR 1.77(b), the specification of a utility application should include the following sections in order. Each of the lettered items should appear in upper case, without underlining or bold type, as a section heading. If no text follows the section heading, the phrase “Not Applicable” should follow the section heading: (a) TITLE OF THE INVENTION. (b) CROSS-REFERENCE TO RELATED APPLICATIONS. (c) STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT. (d) THE NAMES OF THE PARTIES TO A JOINT RESEARCH AGREEMENT. (e) INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A READ-ONLY OPTICAL DISC, AS A TEXT FILE OR AN XML FILE VIA THE PATENT ELECTRONIC SYSTEM. (f) STATEMENT REGARDING PRIOR DISCLOSURES BY THE INVENTOR OR A JOINT INVENTOR. (g) BACKGROUND OF THE INVENTION. (1) Field of the Invention. (2) Description of Related Art including information disclosed under 37 CFR 1.97 and 1.98. (h) BRIEF SUMMARY OF THE INVENTION. (i) BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S). (j) DETAILED DESCRIPTION OF THE INVENTION. (k) CLAIM OR CLAIMS (commencing on a separate sheet). (l) ABSTRACT OF THE DISCLOSURE (commencing on a separate sheet). (m) SEQUENCE LISTING. (See MPEP § 2422.03 and 37 CFR 1.821 - 1.825). A “Sequence Listing” is required on paper if the application discloses a nucleotide or amino acid sequence as defined in 37 CFR 1.821(a) and if the required “Sequence Listing” is not submitted as an electronic document either on read-only optical disc or as a text file via the patent electronic system. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 5-7 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The term “effectively inhibited” recited in claims 5 and 6 is a relative term which renders the claims indefinite. The term is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. It is unclear as to how much inhibition is required in order for the inhibition to be considered “effective” as claimed. For example, it is unclear as to if the term “effective” means that a certain percentage, such as over 50%, or over 75% or some other number must be achieved, or if some property must be modified in order for “effective inhibition” to occur. Claim 6 depends from claim 5 and recites “wherein the condition for effectively inhibiting the activity of the polyphenol oxidase…”. It is unclear as to if “the condition” which is being further limited is in relation to the conditions of grinding recited in claim 5, line 3, and which are the only “conditions” explicitly recited, or as to if “the condition” recited in claim 6 is in relation to the step of inactivating polyphenol oxidase which would inherently have at least one condition present. It is suggested that applicant use letters, such as step a, b, etc., to identify each step and aid in clarity. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 5-7 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Montoya et al (“Enhanced pink-red hues in processed powders from unfermented cacao beans” Food Science and Technology pages 1-7). Regarding claims 5 and 7, Montoya et al (Montoya) teaches a method of product a cacao fruit ground product comprising: enzymatic inactivation of polyphenol oxidase at 93-97C for 5 minutes; then cooling; drying until a moisture content of less than 9%; and then grinding (abstract and sections 2.3 and 2.4). It is noted that as the drying was until a moisture content of less than 9% was reached, the grinding would take place under conditions that had moisture present, i.e. in an amount of up to less than 9%. Additionally, as polyphenol oxidase inactivation was before grinding, grinding as taught by Montoya would be under conditions such that activity of polyphenol oxidase derived from the cacao fruits is “effectively” inhibited. Regarding claim 6, as discussed above the claimed limitation is unclear. Regardless, as Montoya teaches that the cacao fruits are treated with acid before grinding and that the polyphenol oxidase is inactive (abstract and section 2.3), the teachings of Montoya are considered to encompass the invention as claimed. The position of the office is further supported as the acidic condition is disclosed as being provided by citric acid (instant specification paragraph 52), and as Montoya teaches the application of citric acid (abstract and section 2.3). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KELLY BEKKER whose telephone number is (571)272-2739. The examiner can normally be reached Monday-Friday 8am-3:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Erik Kashnikow can be reached at 571-270-3475. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. KELLY BEKKER Primary Patent Examiner Art Unit 1792 /KELLY J BEKKER/Primary Patent Examiner, Art Unit 1792
Read full office action

Prosecution Timeline

Nov 28, 2023
Application Filed
Feb 01, 2026
Non-Final Rejection — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12575588
Natural Pet Chew Product and Method of Manufacture
2y 5m to grant Granted Mar 17, 2026
Patent 12490753
VEGAN ALTERNATIVE TO CHEESE (II)
2y 5m to grant Granted Dec 09, 2025
Patent 11109609
NON-DAIRY HIGH-DENSITY KOSHER FROZEN DESSERT PRODUCT AND PROCESS THEREFOR
2y 5m to grant Granted Sep 07, 2021
Patent 11051539
LOW SODIUM SALT SUBSTITUTE WITH POTASSIUM CHLORIDE
2y 5m to grant Granted Jul 06, 2021
Patent 10980264
THERMALLY INHIBITED AGGLOMERATED STARCH
2y 5m to grant Granted Apr 20, 2021
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
16%
Grant Probability
50%
With Interview (+34.2%)
4y 4m
Median Time to Grant
Low
PTA Risk
Based on 409 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month